Picky Portfolio

client

MedGenome, now Signios Bio, is a global leader in genetic testing and genomics research. They integrate multiomics and bioinformatics to decode complex disease biology. By combining data across genomics, transcriptomics, proteomics, epigenomics, metabolomics, and microbiomics, their AI-powered platform uncovers hidden patterns, driving breakthroughs in the development of new therapies and diagnostics.

client

MedGenome, now Signios Bio, is a global leader in genetic testing and genomics research. They integrate multiomics and bioinformatics to decode complex disease biology. By combining data across genomics, transcriptomics, proteomics, epigenomics, metabolomics, and microbiomics, their AI-powered platform uncovers hidden patterns, driving breakthroughs in the development of new therapies and diagnostics.

client

MedGenome, now Signios Bio, is a global leader in genetic testing and genomics research. They integrate multiomics and bioinformatics to decode complex disease biology. By combining data across genomics, transcriptomics, proteomics, epigenomics, metabolomics, and microbiomics, their AI-powered platform uncovers hidden patterns, driving breakthroughs in the development of new therapies and diagnostics.

focus

As Senior Art Director at Audacity Health, I led the creative process in developing a fresh and cohesive brand identity. Working closely with the team, we focused on refining their visual expression to better align with their mission of advancing genomic and multiomics research. I crafted new brand guidelines and marketing materials that reflect the company's leadership in the precision medicine space. The goal was to create a more modern and impactful presence while maintaining MedGenome's reputation for cutting-edge science.

focus

As Senior Art Director at Audacity Health, I led the creative process in developing a fresh and cohesive brand identity. Working closely with the team, we focused on refining their visual expression to better align with their mission of advancing genomic and multiomics research. I crafted new brand guidelines and marketing materials that reflect the company's leadership in the precision medicine space. The goal was to create a more modern and impactful presence while maintaining MedGenome's reputation for cutting-edge science.

focus

As Senior Art Director at Audacity Health, I led the creative process in developing a fresh and cohesive brand identity. Working closely with the team, we focused on refining their visual expression to better align with their mission of advancing genomic and multiomics research. I crafted new brand guidelines and marketing materials that reflect the company's leadership in the precision medicine space. The goal was to create a more modern and impactful presence while maintaining MedGenome's reputation for cutting-edge science.

result

The new brand identity and assets for client-facing materials were successfully rolled out. These efforts ensured the company’s visual language was unified and engaging, clearly reflecting their leadership in genomics and commitment to driving medical breakthroughs. The redesigned brand strengthened their position as a trusted partner for global research and development in precision medicine, with clear and compelling assets that resonated with key stakeholders.

result

The new brand identity and assets for client-facing materials were successfully rolled out. These efforts ensured the company’s visual language was unified and engaging, clearly reflecting their leadership in genomics and commitment to driving medical breakthroughs. The redesigned brand strengthened their position as a trusted partner for global research and development in precision medicine, with clear and compelling assets that resonated with key stakeholders.

result

The new brand identity and assets for client-facing materials were successfully rolled out. These efforts ensured the company’s visual language was unified and engaging, clearly reflecting their leadership in genomics and commitment to driving medical breakthroughs. The redesigned brand strengthened their position as a trusted partner for global research and development in precision medicine, with clear and compelling assets that resonated with key stakeholders.